DURHAM, N.C., Aug. 27, 2015 /PRNewswire-iReach/ A new study appearing in STEM CELLS Translational Medicine indicates that stem cell injections helped rats live almost a third longer than normal. In addition, the treated animals remained both physically and mentally active longer throughout their life spans.
The study was conducted by researchers in Korea, led by YunBae Kim, D.V.M., Ph.D., at Chungbuk National University’s College of Veterinary Medicine, and Jeong Chan Ra, D.V.M., Ph.D., at the Biostar Stem Cell Research Center, Biostar Group, in Seoul.
Aging is characterized by the loss of regenerative capacity of cells and tissues, leading to the shrinkage of body mass and increased susceptibility to stress. "When new cells are not able to replace the ones that die, tissue integrity and functions decline. Therefore, it has been suggested that exhaustion of stem cells may be a major cause of aging in humans and that the proliferative potential of stem cells is related to life span," said Dr. Kim.
His group wondered whether replenishing stem cells might have an antiaging effect. Their curiosity was sparked by studies conducted on mice suffering from progeria, an extremely rare genetic disorder that causes premature aging. The animals’ lives were extended after receiving stem cell treatments. Other studies indicated improved cognitive function in mice with Alzheimer's disease that were also treated with stem cells.
The KimRa team decided to test whether stem cell treatments might have the same benefits for healthy animals.
To carry out their study, they divided 10-month-old male rats into two groups and intravenously transplanted each group with either human amniotic-membrane-derived mesenchymal stem cells (AMMSCs) or adiposetissuederived mesenchymal stem cells (ADMSCs). The transplantations were carried out once a month for the remainder of the animals’ lives. The animals were compared to a control group of 7monthold rats that received no cells.
At the end of the 20month study, only 30 percent of the control group survived, compared to 70 percent and 100 percent of the animals in the AMMSC and ADMSC groups, respectively. "Collectively, the mean life span of the rats (604.6 days) was extended to 746.0 days (23.4 percent increase) and 793.8 days (31.3 percent increase) by treatment with AMMSCs and ADMSCs, respectively. The animals also remained both cognitively and physically active longer than normal, too," Dr. Kim said.
"We think these improvements in cognitive and motor functions might be due to the increased ACh (acetylcholine concentration, a major neurotransmitter or message sender)levels in the brain and muscles originating not only from the transplanted stem cells, but also from restored neurons," Dr. Ra added. "These results could be a starting point for more studies on ways to achieve similar results in humans, extending their health and lifespans using their own stem cells, too."
"As this line of research progresses, it will be interesting to learn more about the mechanisms behind these results and whether they will apply to other species," said Anthony Atala, M.D., EditorinChief of STEM CELLS Translational Medicine and Director of the Wake Forest Institute for Regenerative Medicine.
Article: "HealthspanExtending Activity of Human Amniotic Membrane and Adipose TissueDerived Stem Cells in F344 Rats," YunBae Kim, Jeong Chan Ra, Sung Geun Kang et al. (DOI: 10.5966/sctm.2015-0011). The article can be accessed at http://StemCellsTM.com/.
About STEM CELLS Translational Medicine: STEM CELLS Translational Medicine (SCTM) is a monthly peer-reviewed publication dedicated to significantly advancing the clinical utilization of stem cell molecular and cellular biology. By bridging stem cell research and clinical trials, SCTM will help move applications of these critical investigations closer to accepted best practices.
About AlphaMed Press: Established in 1983, AlphaMed Press, which has offices in Durham, NC, San Francisco, CA, and Belfast, Northern Ireland, is the publisher of three internationally renowned peer-reviewed journals: STEM CELLS Translational Medicine® (www.StemCellsTM.com), currently in its 4th year, is dedicated to significantly advancing the clinical utilization of stem cell molecular and cellular biology. STEM CELLS® (www.StemCells.com), celebrating its 33rd year, is the world's first journal devoted to this fast paced field of research. The Oncologist® (www.TheOncologist.com), which is entering its 20th year, is devoted to community and hospitalbased oncologists and physicians entrusted with cancer patient are.